SE9702681D0 - Method and composition for treatment of impotence - Google Patents

Method and composition for treatment of impotence

Info

Publication number
SE9702681D0
SE9702681D0 SE9702681A SE9702681A SE9702681D0 SE 9702681 D0 SE9702681 D0 SE 9702681D0 SE 9702681 A SE9702681 A SE 9702681A SE 9702681 A SE9702681 A SE 9702681A SE 9702681 D0 SE9702681 D0 SE 9702681D0
Authority
SE
Sweden
Prior art keywords
impotence
treatment
composition
compositions
transurethral
Prior art date
Application number
SE9702681A
Other languages
English (en)
Swedish (sv)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9702681A priority Critical patent/SE9702681D0/xx
Publication of SE9702681D0 publication Critical patent/SE9702681D0/xx
Priority to JP2000501755A priority patent/JP2001509485A/ja
Priority to EP98934081A priority patent/EP1003520B1/de
Priority to PCT/SE1998/001367 priority patent/WO1999002164A1/en
Priority to AU83682/98A priority patent/AU752049B2/en
Priority to CA002295721A priority patent/CA2295721A1/en
Priority to DE69819515T priority patent/DE69819515T2/de
Priority to US09/462,450 priority patent/US6476074B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9702681A 1997-07-10 1997-07-10 Method and composition for treatment of impotence SE9702681D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence
JP2000501755A JP2001509485A (ja) 1997-07-10 1998-07-10 勃起不全を処置するための方法および組成物
EP98934081A EP1003520B1 (de) 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
PCT/SE1998/001367 WO1999002164A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
AU83682/98A AU752049B2 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
CA002295721A CA2295721A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
DE69819515T DE69819515T2 (de) 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
US09/462,450 US6476074B1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence

Publications (1)

Publication Number Publication Date
SE9702681D0 true SE9702681D0 (sv) 1997-07-10

Family

ID=20407719

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence

Country Status (8)

Country Link
US (1) US6476074B1 (de)
EP (1) EP1003520B1 (de)
JP (1) JP2001509485A (de)
AU (1) AU752049B2 (de)
CA (1) CA2295721A1 (de)
DE (1) DE69819515T2 (de)
SE (1) SE9702681D0 (de)
WO (1) WO1999002164A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
KR20020038793A (ko) 1999-10-07 2002-05-23 우에노 도시오 발기부전 치료제
EP1108426A3 (de) * 1999-12-02 2002-10-02 Pfizer Products Inc. Anwendung von Prostaglandinagonisten zur Behandlung der Erektionstörungen und Impotenz
PT1132086E (pt) 2000-01-31 2006-09-29 Pfizer Prod Inc Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
KR20030019628A (ko) * 2000-07-31 2003-03-06 오노 야꾸힝 고교 가부시키가이샤 프로스타글란딘 유도체를 유효 성분으로 하는 발기부전치료제
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
KR100702368B1 (ko) * 2001-07-16 2007-04-02 에프. 호프만-라 로슈 아게 프로스타노이드 작용제로서의 2 피롤리돈 유도체
KR100826866B1 (ko) 2001-07-23 2008-05-06 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하질환의 치료제
WO2003103772A1 (en) * 2002-06-06 2003-12-18 Merck Frosst Canada & Co. 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
DK1563846T3 (da) 2002-10-10 2012-12-17 Ono Pharmaceutical Co Endogene reparationsfaktorproduktionsfremmere
JP4662926B2 (ja) 2003-03-03 2011-03-30 メルク セローノ ソシエテ アノニム プロスタグランジン作動薬としてのγ−ラクタム誘導体
EP1654219A2 (de) 2003-07-18 2006-05-10 Applied Research Systems ARS Holding N.V. Hydrazinderivate als modulatoren des prostaglandinrezeptors
DE602005019090D1 (de) 2004-12-06 2010-03-11 Merck Serono Sa Coinsins Pyrrolidin-2-on-Derivate zur Verwendung als DP1-Rezeptoragonisten
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
AU2007233212B2 (en) * 2006-04-04 2012-09-13 Allergan, Inc. Therapeutic prostaglandin compounds for the treatment of glaucoma
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US20150272874A1 (en) 2012-10-29 2015-10-01 Cardio Incorporated Pulmonary disease-specific therapeutic agent
JP6449166B2 (ja) 2013-10-15 2019-01-09 小野薬品工業株式会社 薬剤溶出性ステントグラフト
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190670A (en) * 1974-03-26 1980-02-26 Gist Brocades N.V. Prostaglandin derivatives
WO1993000894A1 (en) 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction

Also Published As

Publication number Publication date
US6476074B1 (en) 2002-11-05
JP2001509485A (ja) 2001-07-24
WO1999002164A1 (en) 1999-01-21
AU8368298A (en) 1999-02-08
DE69819515T2 (de) 2004-09-23
EP1003520A1 (de) 2000-05-31
DE69819515D1 (de) 2003-12-11
AU752049B2 (en) 2002-09-05
CA2295721A1 (en) 1999-01-21
EP1003520B1 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
SE9702681D0 (sv) Method and composition for treatment of impotence
IL141120A0 (en) Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
EA200300387A1 (ru) Ингибиторы рецептора ep4 для лечения ревматоидного артрита
PT957914E (pt) Formulacao de agonistas de 5-ht
FR12C0052I2 (fr) Utilisation de dapoxetine, un inhibiteur selectif de recaptage de serotonine a action rapide, pour traiter un dysfonctionnement sexuel
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
IS2882B (is) Samsetning epóþílonhliðstæðna og virkra efna til efnameðferðar til þess að meðhöndla frumufjölgunarsjúkdóma
NO20001744L (no) FremgangsmÕter for Õ behandle psykose forbundet med glykokortikoidrelatert dysfunksjon
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
UY27465A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus con 4' modificaciones nucleosides
NZ511131A (en) Estrogen agonists/antagonists and cGMP elevators for treating female sexual dysfunction
NO982264D0 (no) Inhibitorer av cyklofilinrotamaseaktivitet
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
FI954944A0 (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon
HK1029520A1 (en) Method for preventing hiv-1 infection of cd4+ cells
DE60113290D1 (de) Behandlung von sexueller funktionsstörung mit bombesin rezeptor antagonisten
DK1117403T3 (da) MGLUR5-antagonister til behandling af smerte og angst
DE60011748D1 (de) Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
ES2178851T3 (es) Procedimiento para el tratamiento de un articulo que contienen un compuesto organico oxidable.
EP1108426A3 (de) Anwendung von Prostaglandinagonisten zur Behandlung der Erektionstörungen und Impotenz
BR9809848A (pt) Composição
MXPA03004547A (es) Agonistas receptores de d4 de dopamina selectivos para el tratamiento de disfuncion sexual.